CRAd-synNotch introduces the COX-2 promotor gene upstream of the E1 region, which is responsible for amplifying the adenovirus vector, thereby causing replication only within COX-2 expressing cancer cells and leading to tumor oncolysis. This evidence concerns the gene PTGS2 and neoplasm.